Senseonics Holdings, Inc. Schedules Third Quarter 2021 Earnings Release and Conference Call for November 9, 2021, at 4:30 p.m. Eastern Time
October 26 2021 - 4:05PM
Business Wire
Senseonics Holdings, Inc. (NYSE-American: SENS), a medical
technology company focused on the development and commercialization
of long-term, implantable continuous glucose monitoring (CGM)
systems for people with diabetes, today announced that it plans to
release its third quarter 2021 financial results after market close
on Tuesday, November 9, 2021.
Management will hold a conference call to review the Company’s
third quarter 2021 performance starting at 4:30 p.m. (Eastern Time)
on the same day. The conference call will be concurrently webcast.
The link to the webcast will be available on Senseonics Holdings,
Inc. website at www.senseonics.com by navigating to “Investor
Relations,” and then “Events & Publications,” and will be
archived there for future reference. To listen to the conference
call, please dial 1-888-317-6003 (US/Canada) or 1-412-317-6061
(International), passcode 6493474, approximately ten to five
minutes prior to start time.
About Senseonics
Senseonics Holdings, Inc. is a medical technology company
focused on the design, development and commercialization of
transformational glucose monitoring products designed to help
people with diabetes confidently live their lives with ease.
Senseonics' CGM systems, Eversense® and Eversense® XL, include a
small sensor inserted completely under the skin that communicates
with a smart transmitter worn over the sensor. The glucose data are
automatically sent every 5 minutes to a mobile app on the user's
smartphone.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20211026005342/en/
Senseonics Investor Contact Lynn Lewis or Philip Taylor
Investor Relations 415-937-5406 investors@senseonics.com
Senseonics (AMEX:SENS)
Historical Stock Chart
From Jun 2024 to Jul 2024
Senseonics (AMEX:SENS)
Historical Stock Chart
From Jul 2023 to Jul 2024